SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (NASDAQ: BSGM) on November 7, 2019, covering events occurring on November 6 and November 7, 2019. The registrant is an emerging growth company incorporated in Delaware with principal executive offices in Westport, Connecticut.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and personnel announcements rather than financial performance data.
Material Changes and Events
- Personnel Appointment: On November 6, 2019, the Company appointed Ms. Sasha Gentling, CFA, as Director of Business Development and Investments, expanding its Investor Relations team.
- Executive Philanthropy: On November 7, 2019, Kenneth L. Londoner, the Company's founder, Chairman, and CEO, announced a gift to Union College in New York to support the school's internship program.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, management commentary on operations, or discussion of risks and contingencies. The document serves solely to disclose the entry into material definitive agreements regarding personnel and the associated press releases.
Key Facts for Investor Verification
- Verify the qualifications and background of the newly appointed Director of Business Development and Investments, Ms. Sasha Gentling.
- Confirm the details of the gift made by CEO Kenneth L. Londoner to Union College as disclosed in the November 7 press release.
- Note that this filing does not contain updated financial statements or operational metrics.